Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00209014
Status:
TERMINATED
Last Update Posted:
2009-05-07
First Post:
2005-09-13
Brief Title:
Phase II Trial of Thalidomide in RefractoryRelapsed Diffuse Large B-Cell Lymphoma and Hodgkins Disease
Sponsor:
Emory University
Organization:
Emory University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-06
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-13
First Submit QC Date:
September 13 2005
Study First Post Date:
2005-09-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-05-06
Last Update Post Date:
2009-05-07
Last Update Post Date Type:
ESTIMATED